Lead Trends, Seize Opportunities

Mike doesn’t talk about his job the way people usually do. There’s no checklist of responsibilities, no rush to explain the tech stack. Instead, he talks about moments—standing in hospital hallways, watching workflows unfold, feeling the relief when something finally works the way it’s supposed to. He talks about people. And if you listen long enough, you realize that’s the point.

As the global shortage of pathology personnel continues, the healthcare industry’s demand for digitalization, automation, and AI has grown significantly. aetherAI (7803), in partnership with Techman Robot (4585) and optical giant Hamamatsu Photonics K.K., jointly introduced the industry-leading “Fully Automated Pathology Slide Scanning Solution,” officially unveiled at the 2025 Healthcare+ Expo Taiwan. This solution integrates Techman Robot’s AI collaborative robot with built

aetherAI has officially submitted its application for listing on the Taiwan Innovation Board, becoming the 10th company to apply this year and highlighting the accelerating momentum of Taiwan’s AI healthcare sector. Backed by major investors—including Quanta Computer, Cathay Venture, and Taiwan Business Bank VC—the company continues to attract significant market attention. One of the biggest highlights is aetherAI’s high-profile board lineup, featuring influential leaders fro

The design system improved product consistency and team efficiency by standardizing UI components and creating a medical-focused icon set. This led to a 40% increase in adoption, 92% team satisfaction, and better collaboration across design and engineering—enhancing clarity, reducing errors, and supporting scalable, user-centered healthcare solutions.

During my internship at aetherAI, I helped evolve the Enzyme design system by rebuilding key components and validating them through testing. This experience taught me that great design is about care, clarity, and collaboration—creating space for teams to move confidently and building trust across design, engineering, and users.

At aetherAI, alongside the product development team, our Regulatory Affairs (RA) partners form a nimble task force. As our products—such...

Published by International Journal of Medical Informatics Volume 194, February 2025, 105692 Abstract Background Differential counting...

What kind of challenges can lead a computer science graduate, originally focused on backend development, to assist healthcare...

At aetherAI, the MIS (Management Information Systems) team operates like the central nervous system of the company, ensuring the smooth...

We are thrilled to announce that aetherAI has officially gone public on the Taiwan Emerging Stock Market as of November 26th! This marks...

Published by Cancers 2024, 16(13), 2449 Interobserver variations in the pathology of common astrocytic tumors impact diagnosis and...

Published by Histopathology 2023 Nov;83(5):771-781 Helicobacter pylori (HP) infection is the most common cause of chronic gastritis...

aetherAI proudly showcased aetherAI Hema at the 2024 Joint Annual Congress of TBMT & HST this past weekend. The event highlighted the...

Published by the American Journal of Pathology Vol. 192, No. 12, Dec. 2022 Mantle cell lymphoma (MCL) is a rare type of B-cell lymphoma...

21 Nov. 2022 台灣實績拓展歐日，以 AI 輔助樹立精準醫療新標準 數位病理及醫療影像 AI 領導廠商 – 雲象科技宣布，今年十月底完成 A+ 輪募資，分別由日本 Ono Digital health Investment,...

This award aims to honor CEO talents under the age of 45, taking leading roles in Taiwan's biomedical industry development. Through three...

27 Sept. 2022 臺大醫院、國泰綜合醫院與雲象科技宣布，三方合作的「大腸鏡即時AI瘜肉偵測 aetherAI Endo」獲得衛福部TFDA醫材許可，加入打擊國人癌症之首—大腸癌的防治工作。這項成果，不僅可望利用AI輔助，提升大腸鏡檢查的效能，並且推動提升大腸癌篩檢...

24- 25 Sept, Taipei This event has played a significant role in gastroenterological development, gathering professionals from Taiwan and...

3 - 6 Spet. ECP 2022, the largest face-to-face gathering of pathologists in Europe was held in Basel, Switzerland. Our AI-powered...

26-28 Aug., Tokyo The 20th JSDP, Japanese Society of Digital Pathology Annual Meeting focused on Digital Pathology and AI research. It is...